🔴 Edesa Biotech is trading 5.8% down today on profit-taking following a multi-day rebound

Edesa Biotech is trading 5.8% down today at $5.05 as investors lock in gains following a sharp multi-day recovery.

• The downward move appears to be driven by profit-taking and volatility after the stock rebounded from a significant selloff in late July.
• There are no new company-specific catalysts, earnings reports, or FDA updates today to account for the price action.
• The decline stands in contrast to the broader biotech sector, which is trading higher as overall markets remain near record highs.